2022 Genomic Archives

Genomic Vision launches HexaCard, a new service for the characterization of transformed cell lines – 07/18/2023 at 07:00

Oliver Adey2 months ago2 months ago01 mins

• HexaCard is an innovative service to improve quality control in cell characterization for bioproduction, cell and gene therapy applications • HexaCard offers a highly accurate analytical method for characterizing transformed cell lines, with the ability to assess six critical parameters in a single assay • HexaCard helps identify transgene stability, cell clonality and provides…

Genomic Vision soars at the announcement of its share buyback program – 06/29/2023 at 10:20 am

Oliver Adey3 months ago3 months ago02 mins

(AOF) – Genomic Vision gained more than 37% to 0.016 euro after publishing a description of its share buyback program. Biotech announces that the maximum share of the capital whose redemption is authorized is equal to 10% of the number of shares making up the share capital on the day of the Meeting, the maximum…

Genomic Vision announces the draw of the 3rd tranche of 2 ME

Oliver Adey3 months ago3 months ago01 mins

By Claude Leguilloux Published on 06/23/2023 at 6:13 p.m. Photo credit © ChaunuPictures (Boursier.com) — Genomic Visiona biotechnology company listed on Euronext developing products and services for the precise characterization of DNA sequences, announces today the issuance of the third tranche of bonds…

Genomic Vision: drawing of the 3rd installment of 2 ME

Oliver Adey3 months ago3 months ago02 mins

By Alexandra Saintpierre Posted on 06/25/2023 at 10:23 p.m. Photo credit © Genomic Vision (Boursier.com) — Genomic Vision issued the 3rd tranche of bonds convertible into shares with share subscription warrants (OCABSA) for a net amount of 1.92 million euros. On June 23,…

Genomic Vision: a 3rd tranche of Ocabsa issued for 1.92 million euros – 06/23/2023 at 18:10

Oliver Adey3 months ago3 months ago03 mins

(AOF) – Genomic Vision has announced the issue of a third tranche of bonds convertible into shares with share subscription warrants (Ocabsa) for a net amount of 1.92 million euros. This biotechnology company developing products and services for the precise characterization of DNA sequences recalls that it had announced the signing of an issuance contract…

Genomic vision: Distribution agreement with CliniSciences

Oliver Adey3 months ago3 months ago02 mins

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service providers. They are kept for the duration of the processing and/or for the duration of the specific processing to which you have consented and/or for…

Finance

Genomic Vision: distribution agreement with CliniSciences

Oliver Adey3 months ago3 months ago01 mins

(CercleFinance.com) – Genomic Vision announced Thursday that it has entered into an exclusive distribution agreement with the French SME CliniSciences with a view to accelerating the marketing of its products in Europe. The biotech company, which specializes in genome editing tools, says the deal will give it access to CliniSciences’ distribution channels and customer base…

Genomic vision: Technology agreement with ICR London

Oliver Adey3 months ago3 months ago02 mins

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service providers. They are kept for the duration of the processing and/or for the duration of the specific processing to which you have consented and/or for…

Finance

Genomic Vision: technology agreement with ICR London

Oliver Adey3 months ago3 months ago01 mins

(CercleFinance.com) – Genomic Vision announced on Tuesday that it has entered into a technological agreement with The Institute of Cancer Research, a cancer research institute based in London. Under the terms of the partnership, Genomic will provide the academic institution with its state-of-the-art fluorescence scanner for molecular combing, FiberVisionS, as well as its advanced AI…

Genomic Vision: New Target Strategy Will Leverage AI for Genomic Analysis – 2023-06-07 14:40

Oliver Adey4 months ago4 months ago03 mins

(AOF) – Genomic Vision, a biotech specialist in the precise characterization of DNA sequences, presented its new strategic orientation. It will work to advance genomic analysis in “biomanufacturing, cell and gene therapies and drug discovery”, but also “innovation for quality control throughout the biomanufacturing cycle”. The company will launch AI-based analysis software and a technology…

Genomic vision: Thanks to the launch of AI-based software, Genomic Vision soars on the stock market

Oliver Adey7 months ago7 months ago05 mins

(BFM Bourse) – The biotech specializing in the analysis of genome modifications and cellular health is experiencing a strong surge on the stock market after announcing the launch of its FiberSmart solution. While the Parisian market is evolving almost at a standstill at the start of the afternoon, Genomic Vision stands out. The biotech title…

Finance

Genomic Vision: launch of FiberSmart technology

Oliver Adey7 months ago7 months ago01 mins

(CercleFinance.com) – Genomic Vision today announces the launch of FiberSmart®, an innovative technology based on artificial intelligence (AI) aimed at automating the detection and quantification of fluorescent signals on combed DNA molecules. Initially, FiberSmart® will be available for the analysis of Replication Combing Assays (RCA), Genomic Vision’s proprietary method for direct visualization of DNA replication…

Change in practice at SEM – Asylum for Afghan women and girls is something to talk about – News

Lvmh: After an 18% fall in 2 months, has LVMH eaten all its black bread on the stock market?

Part of the Golden State Warriors’ capital could change ownership for an astronomical price

Galaxy S24 Ultra: a less powerful processor than expected?

Google once again challenges Apple to adopt the SMS replacement

new blow for the studio, the game in danger?

Genomic

Genomic Vision launches HexaCard, a new service for the characterization of transformed cell lines – 07/18/2023 at 07:00

Genomic Vision announces the draw of the 3rd tranche of 2 ME

Genomic Vision: drawing of the 3rd installment of 2 ME

Genomic Vision: a 3rd tranche of Ocabsa issued for 1.92 million euros – 06/23/2023 at 18:10

Genomic vision: Distribution agreement with CliniSciences

Genomic Vision: distribution agreement with CliniSciences

Genomic vision: Technology agreement with ICR London

Genomic Vision: technology agreement with ICR London

Genomic Vision: New Target Strategy Will Leverage AI for Genomic Analysis – 2023-06-07 14:40

Genomic vision: Thanks to the launch of AI-based software, Genomic Vision soars on the stock market

Genomic Vision: launch of FiberSmart technology